160 related articles for article (PubMed ID: 29446085)
21. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.
Kuraoka K; Matsumura S; Sanada Y; Nakachi K; Imai K; Eguchi H; Matsusaki K; Oue N; Nakayama H; Yasui W
Oncol Rep; 2005 Aug; 14(2):465-70. PubMed ID: 16012731
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
24. Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression.
Deng R; Wu H; Ran H; Kong X; Hu L; Wang X; Su Q
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1065-1074. PubMed ID: 28237576
[TBL] [Abstract][Full Text] [Related]
25. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
26. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.
Nam EH; Lee Y; Zhao XF; Park YK; Lee JW; Kim S
Carcinogenesis; 2014 Feb; 35(2):302-14. PubMed ID: 24130169
[TBL] [Abstract][Full Text] [Related]
27. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.
Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B
Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475
[TBL] [Abstract][Full Text] [Related]
28. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
29. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
30. Impact of MDM2 polymorphism: increased risk of developing colorectal cancer and a poor prognosis in the Tunisian population.
Chaar I; Arfaoui TA; El Amine el HO; Mahmoud LB; Khiari M; Sammoud S; Lounis A; Amara S; Gharbi L; Hmida AB; Mzabi S; Bouraoui S
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):320-7. PubMed ID: 22266832
[TBL] [Abstract][Full Text] [Related]
31. Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
Yu Y; Cheng D; Parfrey P; Liu G; Savas S
PLoS One; 2018; 13(6):e0198873. PubMed ID: 29894502
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
33. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells.
Dong W; Shen R; Wang Q; Gao Y; Qi X; Jiang H; Yao J; Lin X; Wu Y; Wang L
Cancer Biol Ther; 2009 Nov; 8(22):2166-74. PubMed ID: 19783902
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphism rs2555639 in 15-PGDH and colorectal cancer metastasis.
Zhang S; Liu J; Yang M; Fan D; Gao J; Liu X; Li J; Feng H; Lu H; Kang Y
J BUON; 2019; 24(4):1507-1511. PubMed ID: 31646799
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
[TBL] [Abstract][Full Text] [Related]
36. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
37. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
38. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
39. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis.
Wang Q; Qian J; Wang F; Ma Z
Oncol Rep; 2012 Dec; 28(6):2029-34. PubMed ID: 22972305
[TBL] [Abstract][Full Text] [Related]
40. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267.
Gong J; Tian J; Lou J; Wang X; Ke J; Li J; Yang Y; Gong Y; Zhu Y; Zou D; Peng X; Yang N; Mei S; Zhong R; Chang J; Miao X
Ann Oncol; 2018 Mar; 29(3):632-639. PubMed ID: 29267898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
